Perth MedTech BlinkLab (ASX:BB1) Commences Pivotal FDA Study for Smartphone AI Autism Diagnostic

📅 24/03/2026 02:44 📰 nationaltribune 👁️ 6 lectures 🌍 Australie 📂 Santé

Tuesday 24th March 2026 | BlinkLab (ASX:BB1, Perth Australia) Commences Pivotal US FDA Clinical Trial | First Participant Enrolled in Autism